Human Argonaute proteins are key components of the RNA interference (RNAi) pathway, which is a gene-regulatory mechanism that silences gene expression by targeting specific messenger RNAs (mRNAs) for degradation. There are four Argonaute proteins in humans: Ago1, Ago2, Ago3, and Ago4. Each of these proteins has a specific role in the RNAi pathway, and they can be broadly categorized into two groups based on their slicing activity:

Slicer Ago proteins (Ago2): Ago2 is the primary slicer Argonaute protein in humans. It contains a PAZ (Piwi/Argonaute/Zwille) domain that binds to the 3' end of small interfering RNAs (siRNAs) or microRNAs (miRNAs), and a PIWI domain that cleaves the target mRNA. Ago2-mediated mRNA cleavage leads to the degradation of the mRNA and silencing of gene expression.

Non-slicer Ago proteins (Ago1, Ago3, and Ago4): Ago1, Ago3, and Ago4 lack the catalytic activity required for mRNA cleavage. Instead, they function as guides for miRNAs and siRNAs, directing them to their target mRNAs. These non-slicer Ago proteins can also interact with other proteins to regulate gene expression through mechanisms that do not involve mRNA cleavage.

The choice of whether to slice or not to slice an mRNA molecule depends on the specific Argonaute protein involved and the cellular context. In general, Ago2 is responsible for slicing mRNAs that are targeted by siRNAs, while Ago1, Ago3, and Ago4 guide miRNAs to their target mRNAs and regulate gene expression through non-slicing mechanisms.